Link: https://www.goodrx.com/conditions/breast-cancer/aromasin-vs-arimidex-for-breast-cancer
Description: WEBAug 27, 2021 · Aromasin and Arimidex are medications used in hormone therapy to treat breast cancer. Both are aromatase inhibitors, and both are similarly effective — though results vary based on the individual’s response to treatment. Learn more about Aromasin and Arimidex with GoodRx.
DA: 43 PA: 86 MOZ Rank: 80
Link: https://www.singlecare.com/blog/arimidex-vs-aromasin/
Description: WEBMay 16, 2023 · Arimidex and Aromasin are brand-name hormone therapy medications that treat hormone receptor-positive breast cancer. By lowering estrogen levels in the body, these medications help slow or stop the growth of breast cancer cells. Arimidex and Aromasin can only be obtained with a prescription.
DA: 82 PA: 11 MOZ Rank: 75
Link: https://www.healthcentral.com/article/aromatase-inhibitor-faqs-hormone-therapy-arimidex-femara-and-aromasin-for-breast-cancer
Description: WEBJan 22, 2024 · Aromasin and Arimidex for Breast Cancer: What’s the Difference? Both of these aromatase inhibitors treat cancer by lowering estrogen levels but come with different interactions and side...
DA: 80 PA: 99 MOZ Rank: 56
Link: https://www.drugs.com/compare/arimidex-vs-aromasin
Description: WEBCompare Arimidex vs Aromasin head-to-head with other drugs for uses, ratings, cost, side effects and interactions.
DA: 80 PA: 4 MOZ Rank: 92
Link: https://e-bp.org/blog/aromasin-vs-arimidex-breast-cancer-treatment/
Description: WEBFeb 27, 2024 · Efficacy: Both Arimidex and Aromasin are highly effective, yet their nuances may sway the decision for one over the other based on individual patient factors. Side Effects : While both share common side effects, the intensity and personal impact may vary, influencing choice.
DA: 84 PA: 67 MOZ Rank: 71
Link: https://www.cancer.org/cancer/types/breast-cancer/risk-and-prevention/aromatase-inhibitors-for-lowering-breast-cancer-risk.html
Description: WEBAnastrozole (Arimidex) Exemestane (Aromasin) Like tamoxifen, these drugs are more often used to treat hormone receptor-positive breast cancer than to lower breast cancer risk. When used to lower breast cancer risk, these drugs are typically taken for 5 years. They are pills taken once a day. Can aromatase inhibitors lower the risk of breast cancer?
DA: 1 PA: 63 MOZ Rank: 87
Link: https://www.mayoclinic.org/tests-procedures/hormone-therapy-for-breast-cancer/about/pac-20384943
Description: WEBMar 22, 2023 · Anastrozole (Arimidex). Exemestane (Aromasin). Letrozole (Femara). These medicines can reduce the risk of cancer recurrence in those who have been treated for early-stage breast cancer. Aromatase inhibitors also can be …
DA: 97 PA: 61 MOZ Rank: 100
Link: https://www.komen.org/breast-cancer/facts-statistics/research-studies/topics/aromatase-inhibitors-for-early-breast-cancer/
Description: WEBThe aromatase inhibitors anastrozole (Arimidex), exemestane (Aromasin) and letrozole (Femara) all have a similar treatment benefit [1]. They also have similar side effects. However, a person may tolerate one drug better than another. Learn more about aromatase inhibitors, including possible side effects.
DA: 35 PA: 9 MOZ Rank: 16
Link: https://www.komen.org/breast-cancer/treatment/type/hormone-therapy/aromatase-inhibitors/
Description: WEBHormone receptor-positive breast cancers need estrogen (a female hormone) to grow. Aromatase inhibitors lower estrogen levels in the body by blocking aromatase, an enzyme that converts other hormones into estrogen. This slows or stops the growth of the tumor by preventing the cancer cells from getting the hormones they need to grow.
DA: 56 PA: 15 MOZ Rank: 84
Link: https://www.mayoclinic.org/diseases-conditions/breast-cancer/in-depth/breast-cancer/art-20045353
Description: WEBOct 28, 2023 · Three aromatase inhibitors are currently approved in the United States for breast cancer treatment: anastrozole (Arimidex), exemestane (Aromasin) and letrozole (Femara). These medications are used to treat breast cancer that's estrogen- or progesterone-responsive in those who've undergone menopause.
DA: 19 PA: 73 MOZ Rank: 7
